| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 04/18/2013 | US20130096150 Substituted Azoanthracene Derivatives, Pharmaceutical Compositions, and Methods of Use Thereof |
| 04/18/2013 | US20130096128 Pyrazole compounds useful as protein kinase inhibitors |
| 04/18/2013 | CA2851810A1 Substituted tetrahydroisoquinoline compounds as factor xia inhibitors |
| 04/18/2013 | CA2850394A1 Indazole compounds as kinase inhibitors and method of treating cancer with same |
| 04/17/2013 | EP2581365A1 Heterocyclic compound, organic light-emitting diode comprising the heterocyclic compound, and flat panel display device comprising the organic light-emitting diode |
| 04/17/2013 | CN103052641A Novel fused heterocyclic derivatives useful as C-Met tyrosine kinase inhibitors |
| 04/17/2013 | CN103052640A Furopyridine derivatives |
| 04/17/2013 | CN103044437A Amphiphilic conjugate nano-particle for treating tumors, as well as preparation method and application of same |
| 04/17/2013 | CN103044436A Synthesis method of dimethyl 1-benzyl-3,4-ethylene dioxypyrrole-2,5-dicarboxylate |
| 04/17/2013 | CN102070630B New tiotropium salts, pharmaceutical compositions containing the same and use thereof |
| 04/17/2013 | CN101891750B Preparation method of stephanine and hydrochloride thereof |
| 04/16/2013 | US8420638 Triheterocyclic compounds and compositions thereof |
| 04/16/2013 | CA2548273C Substituted 6-cyclohexylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 04/11/2013 | WO2013051672A1 Medicinal agent comprising thiazolidine derivative or salt thereof as active ingredient |
| 04/11/2013 | WO2013050757A1 1-pyrazolyl-3- (4- ( (2 -anilinopyrimidin- 4 - yl) oxy) napththalen- 1 - yl) ureas as p38 map kinase inhibitors |
| 04/11/2013 | US20130090353 Noxious arthropod control composition and heterocyclic compound |
| 04/11/2013 | US20130087768 Heterocyclic compound, organic light-emitting diode comprising the heterocyclic compound, and flat panel display device comprising the organic light-emitting diode |
| 04/11/2013 | CA2846222A1 1-pyrazolyl-3- (4- ( (2 -anilinopyrimidin- 4 - yl) oxy) napththalen- 1 - yl) ureas as p38 map kinase inhibitors |
| 04/10/2013 | EP2578084A1 Noxious organism control agent |
| 04/10/2013 | EP2575766A1 Novel pharmaceutical compounds |
| 04/10/2013 | EP2575464A1 New forms of rifaximin and uses thereof |
| 04/10/2013 | CN103037694A Noxious arthropod control composition, and heterocyclic compound |
| 04/10/2013 | CN103030634A Bicyclo-containing oxazolidinone antibiotics |
| 04/10/2013 | CN103030585A Heterocyclic compound, organic light-emitting diode and flat panel display device |
| 04/10/2013 | CN102206222B 2-fatty-amino-substituted indole quinoline derivative and preparation method and application thereof in preparation of antitumor drugs |
| 04/10/2013 | CN101962384B Chromene compounds, a process for their preparation and pharmaceutical compositions containing them |
| 04/10/2013 | CN101195599B 2,4,6-phenyl substituted cyclic ketoenols |
| 04/09/2013 | US8415348 Nitrogenated derivatives of pancratistatin |
| 04/09/2013 | US8415347 Substituted tetracyclic tetahydrofuran, pyrrolidine and tetrahydrothiophene derivatives |
| 04/09/2013 | US8415333 Bronchodilating diazaheteroaryls |
| 04/04/2013 | WO2013046635A1 Material for organic electroluminescent element, and organic electroluminescent element produced using same |
| 04/04/2013 | WO2013045461A1 Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use |
| 04/04/2013 | WO2013044865A1 Oxazolidinone antibiotics containing fused ring |
| 04/04/2013 | WO2013007361A8 Crystalline (1r,4r)-6'-fluoro-n,n-dimethyl-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine |
| 04/04/2013 | US20130085134 Quinoxaline compound |
| 04/04/2013 | US20130081999 Bridged Macrocyclic Module Compositions |
| 04/04/2013 | DE112011101447T5 Bicarbazol enthaltende Verbindungen für OLEDs Bicarbazol containing compounds for OLEDs |
| 04/04/2013 | CA2845191A1 Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use |
| 04/03/2013 | CN103025738A Furopyridine compounds and uses thereof |
| 04/03/2013 | CN103025161A Noxious organism control agent |
| 04/03/2013 | CN103012428A 4-(five-membered heterocycle pyrimidin/substituted pyridine) amino-1H-3-pyrazolecarboxamide CDK (cyclin dependent kinase)/Aurora dual inhibitor and application thereof |
| 04/03/2013 | CN103012422A Preparation and application of 5,11-methylenemorphanthridine compound |
| 04/03/2013 | CN103012421A Isoquinoline drug, its preparation and application |
| 04/03/2013 | CN103012420A Lycorine derivative, veterinary drug taking lycorine derivative as an active constituent, and applications of lycorine derivative |
| 04/03/2013 | CN103012419A Method for synthesizing rhodamine B derivatives |
| 04/03/2013 | CN103012418A 1,3,4-oxadizaole structure unit-containing Rhodamine B pH fluorescence probe and applications thereof |
| 04/03/2013 | CN103012417A Carbazole alkaloids in clausena plants, medicine composition with carbazole alkaloids as anti-tumor active component, and preparation method and application of carbazole alkaloids |
| 04/02/2013 | CA2564085C Heterocyclic amide compound and use thereof as an mmp-13 inhibitor |
| 04/02/2013 | CA2475633C Heteroaryl compounds useful as inhibitors of gsk-3 |
| 03/28/2013 | WO2013043744A2 Tricyclic compounds useful as neurogenic and neuroprotective agents |
| 03/28/2013 | WO2013041604A1 Crystal form of asenapine maleate |
| 03/28/2013 | WO2013041176A1 Carbazole derivatives for organic electroluminescence devices |
| 03/28/2013 | WO2013040669A1 Compounds of the family of pterocarpan quinones, method for producing same, pharmaceutical composition, uses thereof and therapeutic method |
| 03/28/2013 | WO2013013068A3 Embodiments of a probe and method for targeting nucleic acids |
| 03/28/2013 | WO2012172438A3 Compositions and methods for modulating a kinase |
| 03/28/2013 | US20130079366 Benzisoxazoles and Azabenzisoxazoles as MGLUR4 Allosteric Potentiators, Compositions, and Methods of Treating Neurological Dysfunction |
| 03/28/2013 | US20130079323 Gyrase inhibitors |
| 03/28/2013 | CA2849087A1 Carbazole derivatives for organic electroluminescent devices |
| 03/27/2013 | CN102994072A Fluorescent probe for detecting hypochlorite aions, and preparation method thereof |
| 03/27/2013 | CN102993209A Method for separating camptothecin by use of molecular imprinting-matrix solid-phase dispersion technology |
| 03/27/2013 | CN102993208A Noradrenaline and selective serotonin receptor blocking agent and application thereof |
| 03/27/2013 | CN102993207A Rhodamine B-triazine compounds and preparation method and application thereof |
| 03/27/2013 | CN102559510B Halophilic aspergillus sp.F1 and application thereof |
| 03/27/2013 | CN102127088B Naphthalimide-modified rhodamine derivative (naphthalimide modified rhodamine B chemosensor, NRC) and preparation and use thereof |
| 03/27/2013 | CN101627028B Substituted diazepan compounds as orexin receptor antagonists |
| 03/27/2013 | CN101223175B Diazabenzo[de]anthracen-3-one compounds and methods for inhibiting PARP |
| 03/26/2013 | US8404852 Gyrase inhibitors and uses thereof |
| 03/26/2013 | US8404708 Dual NK1/NK3 receptor antagonists |
| 03/26/2013 | CA2683937C Process for making topotecan |
| 03/21/2013 | WO2013038200A2 Neurodevelopmental disorders |
| 03/21/2013 | US20130072690 Chemical Compounds |
| 03/21/2013 | US20130072686 Synthetic methods for spiro-oxindole compounds |
| 03/21/2013 | US20130072677 Novel hydroxamic acid derivative |
| 03/21/2013 | US20130072537 Enantiomers of spiro-oxindole compounds and their uses as therapeutic agents |
| 03/21/2013 | US20130072483 Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use |
| 03/21/2013 | US20130072457 Pyrazolyl quinazoline kinase inhibitors |
| 03/21/2013 | US20130072449 Lysophosphatidic acid receptor antagonists |
| 03/21/2013 | US20130072427 Gpr 119 modulators |
| 03/20/2013 | EP2569320A2 (+)-3-hydroxymorphinan-based polycycle derivatives as neuroprotectants |
| 03/20/2013 | EP2569304A1 Substituted n-heteroaryl spirolactam bipyrrolidines, preparation and therapeutic use thereof |
| 03/20/2013 | EP2569300A1 Nitrogen heterocyclic compounds useful as pde10 inhibitors |
| 03/20/2013 | EP2569298A1 Novel ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments |
| 03/20/2013 | EP2569280A1 Substituted phenyl cycloalkyl pyrrolidine (piperidine) spirolactams and amides, preparation and therapeutic use thereof |
| 03/20/2013 | CN102985405A Heterocyclic compound, and p27 kip1 degradation inhibitor |
| 03/20/2013 | CN102977111A Beta1-epinephrine receptor analgesia with effect of improving Alzheimer disease |
| 03/20/2013 | CN102973947A Antibody-drug conjugates and methods |
| 03/20/2013 | CN102391266B Method for extracting and separating pseudolycorine from lycoris plants |
| 03/20/2013 | CN102002050B Bisbenzylisoquinoline derivative and preparation and application thereof |
| 03/20/2013 | CN101899051B 1-azaxanthone-3-formamide compounds as well as preparation method and antitumor application thereof |
| 03/19/2013 | US8399672 Compound having affinity for amyloid |
| 03/19/2013 | US8399667 4-anilino quinazoline derivatives as antiproliferative agents |
| 03/19/2013 | US8399659 Compounds and methods for inhibiting mitotic progression |
| 03/19/2013 | US8399476 Imidazo[1,2-a]pyridines and their use as pharmaceuticals |
| 03/19/2013 | US8399449 Fused heterocyclic derivative and use thereof |
| 03/19/2013 | CA2562406C Cyclic amine compound |
| 03/14/2013 | WO2013036611A1 Processes and intermediates for making a jak inhibitor |
| 03/14/2013 | WO2013035833A1 Morphinan derivative |
| 03/14/2013 | WO2013035329A1 Organic electroluminescence element |
| 03/14/2013 | WO2013035109A1 Improved process for the preparation of asenapine maleate |
| 03/14/2013 | WO2013034238A1 Benzonitrile derivatives as kinase inhibitors |